THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
155,831,246
Share change
-8,269,713
Total reported value
$821,246,855
Put/Call ratio
60%
Price per share
$5.27
Number of holders
116
Value change
-$59,727,020
Number of buys
60
Number of sells
61

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q2 2017

As of 30 Jun 2017, THERAPEUTICSMD INC - COM (TXMD) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 155,831,246 shares. The largest 10 holders included FMR LLC, Bank of New York Mellon Corp, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, BlackRock Inc., FRANKLIN RESOURCES INC, VANGUARD GROUP INC, STATE STREET CORP, GILDER GAGNON HOWE & CO LLC, and Voya Investment Management LLC. This page lists 116 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.